Dealmaking and Financing: Mergers and Acquisitions in the … - MarketWatch

Dealmaking and Financing: Mergers and Acquisitions in the … - MarketWatch


Dealmaking and Financing: Mergers and Acquisitions in the …
MarketWatch - 23 hours ago
No facet of the biotech, specialty, or generics industries is being ignored; no technology platform, clinical product, or research program is unexplored or …
Discover Key Issues to Consider When Bringing Biologics to Market …MarketWatch
all 17 news articles

A Practical Guide for the Pharmaceutical and Biotech Industries … - MarketWatch

A Practical Guide for the Pharmaceutical and Biotech Industries … - MarketWatch


A Practical Guide for the Pharmaceutical and Biotech Industries …
MarketWatch - 7 hours ago
Pharmaceutical and biotech companies are outsourcing more of their work than ever before - the list includes drug discovery, development, manufacture and …
Explore the Fundamentals of Logistics in Bulgaria MarketWatch
all 14 news articles

Recruiters eye Genentech employees - San Francisco Chronicle

Recruiters eye Genentech employees - San Francisco Chronicle

The Money Times


Recruiters eye Genentech employees
San Francisco Chronicle, USA - 8 hours ago
Analysts predicted a mass exodus of valued Genentech staffers after Roche, which had preserved the biotech pioneer’s independence for years, made a surprise …
Biotech firms play hard to getReuters UK
Just the drug for the biotechs Therapeutics Daily (subscription) (press release)
Roche/Genentech Financial Times
Wall Street Journal - International Herald Tribune
all 293 news articles

Accelerator Corporation Creates Ninth New Biotech Company - FOXBusiness

Accelerator Corporation Creates Ninth New Biotech Company - FOXBusiness


Accelerator Corporation Creates Ninth New Biotech Company
FOXBusiness - 3 hours ago
Accelerator Corporation, founded in 2003, is a privately-held biotechnology investment and development company located in Seattle, Washington, USA. …

Biotech firms play hard to get - Reuters UK

Biotech firms play hard to get - Reuters UK

KCBS


Biotech firms play hard to get
Reuters UK, UK - Aug 13, 2008
Biotechnology company Genentech Inc on Wednesday followed ImClone Systems Incâs playbook by rejecting a takeover bid by its largest shareholder. …
Genentech: rejects Roche bid Pharmaceutical Business Review
Genentech Board Committee Rejects Roche’s $44 Billion Purchase Offer Wall Street Journal
Genentech rejects takeover bid from Roche International Herald Tribune
Forbes - Wall Street Journal Blogs
all 286 news articles

Genentech rejects Roche offer as too low - San Francisco Chronicle

Genentech rejects Roche offer as too low - San Francisco Chronicle

The Money Times


Genentech rejects Roche offer as too low
San Francisco Chronicle, USA - 2 hours ago
(08-13) 18:45 PDT — Biotech giant Genentech Inc. has rejected the surprise $43.7 billion takeover bid it received from Swiss drug giant Roche, …
Biotech firms play hard to getReuters UK
Genentech Board Committee Rejects Roche’s $44 Billion Purchase Offer Wall Street Journal
Genentech rejects takeover bid from Roche International Herald Tribune
Forbes - Wall Street Journal Blogs
all 336 news articles

Biotech Group Expands Partnership Nationally With Wells Fargo - FOXBusiness

Biotech Group Expands Partnership Nationally With Wells Fargo - FOXBusiness


Biotech Group Expands Partnership Nationally With Wells Fargo
FOXBusiness - 2 hours ago
The partnership encompasses participating state and regional biotechnology associations. Combined, over 5200 biotechnology companies and organizations …
Wells Fargo Insurance Services enters into partnership with BIO Insurance Business Review
all 2 news articles

VC-owned companies argue for research program eligibility - MLive.com

VC-owned companies argue for research program eligibility - MLive.com


VC-owned companies argue for research program eligibility
MLive.com, MI - 4 hours ago
They contend small biotech companies are forced to turn to venture capital because bringing new drugs and other innovations to market takes a lot of time …

Biotech-Stock Mailbag: Titan, Gilead - TheStreet.com

Biotech-Stock Mailbag: Titan, Gilead - TheStreet.com


Biotech-Stock Mailbag: Titan, Gilead
TheStreet.com - 12 hours ago
Thanks for returning to the weekly Biotech Mailbag. Our first question comes from Anh N., who asks: “Could you comment on the future of Titan …

Biotech firm proves it is no shrimp - TheChronicleHerald.ca

Biotech firm proves it is no shrimp - TheChronicleHerald.ca


Biotech firm proves it is no shrimp
TheChronicleHerald.ca, Canada - 1 hour ago
By CLARE MELLOR Business Reporter âIt is for healing wounds, burns or cuts, things like that,” Ms. Zazanis said Thursday from New Jersey. …

Next Page »